Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;82(3):654-663.
doi: 10.1007/s12020-023-03483-8. Epub 2023 Aug 19.

Prevalence and predictors of vitamin D deficiency in Lebanon: 2016-2022, before and during the COVID-19 outbreak

Diala Harkous  1 , Nada Ghorayeb  1 , Marie-Hélène Gannagé-Yared  2
Affiliations

Prevalence and predictors of vitamin D deficiency in Lebanon: 2016-2022, before and during the COVID-19 outbreak

Diala Harkous et al. Endocrine. 2023 Dec.

Abstract

Background: Vitamin D deficiency is very common worldwide, particularly in Middle-Eastern countries. Recent Lebanese studies demonstrated an improvement in vitamin D status over time. However, the comparison between the years before and during the COVID-19 outbreak has never been analyzed in the Middle-East area. This study aimed to determine the prevalence and the predictors of 25-hydroxyvitamin D (25(OH)D) levels during the last 7 years.

Methods: Serum 25(OH)D levels from a large laboratory database were retrospectively collected from Hôtel-Dieu de France Hospital between January 2016 and June 2022 (N = 66,127). Data related to age, gender, season and year of sampling were also retrieved.

Results: Mean age of the population was 50.6 ± 19 years, 62.7% were women, 5.3% were children and adolescents, 67.6% adults and 27% elderly. Mean serum 25(OH)D level was 25.7 ± 11.9 ng/mL. The overall population with vitamin D sufficiency (>30 ng/mL) was 31.9%. The increase in mean serum 25(OH)D observed between 2016 and 2022 was 6.36 ng/mL (p < 0.0001). The prevalence of 25(OH)D deficiency (<30 ng/mL) decreased from 76.2% in 2016 to 56.5% in 2022 (p < 0.0001) with a significant difference between the period before and during the COVID-19 outbreak (72.3% vs.42.5%, p < 0.0001). In a multivariate logistic regression, older age, female sex, summer season, years of the COVID-19 outbreak and outpatient samples were protective factors against the risk of hypovitaminosis D (p < 0.0001 for all variables).

Conclusion: Our study showed a continuous positive change in vitamin D status time, most notably after the COVID-19 outbreak. Further studies are needed to assess the clinical impact of the pandemic on vitamin D status in our population.

Keywords: COVID-19; Lebanon; Predictors; Prevalence; Vitamin D.

PubMed Disclaimer

References

    1. A. Zendehdel, M. Arefi, Molecular evidence of role of vitamin D deficiency in various extraskeletal diseases. J. Cell Biochem. 120(6), 8829–8840 (2019). https://doi.org/10.1002/jcb.28185 - DOI - PubMed
    1. R. Bouillon, C. Marcocci, G. Carmeliet, D. Bikle, J.H. White, B. Dawson-Hughes et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr. Rev. 40(4), 1109–1151 (2019). https://doi.org/10.1210/er.2018-00126 - DOI - PubMed
    1. H. Glerup, K. Mikkelsen, L. Poulsen, E. Hass, S. Overbeck, J. Thomsen et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J. Intern. Med. 247(2), 260–268 (2000). https://doi.org/10.1046/j.1365-2796.2000.00595.x - DOI - PubMed
    1. J. Bartley, Vitamin D: emerging roles in infection and immunity. Expert Rev. Anti Infect. Ther. 8(12), 1359–1369 (2010). https://doi.org/10.1586/eri.10.102 - DOI - PubMed
    1. D. Bassil, M. Rahme, M. Hoteit, G.E.H. Fuleihan, Hypovitaminosis D in the Middle East and North Africa: prevalence, risk factors and impact on outcomes. Dermatoendocrinol 5(2), 274–298 (2013). https://doi.org/10.4161/derm.25111 - DOI - PubMed - PMC

LinkOut - more resources